乐观
$162.17
情景价格
$170.730
+0.205 (+0.12%)收盘时
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Balchem Corp is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $167.83, with a forward P/E ratio of 29.33, indicating growth potential. The company reported a 11.2% year-over-year revenue increase in Q2 2026, reaching $284 million, and a gross margin of 36.5%, which reflects robust profitability. However, a risk to consider is the significant insider selling, which has increased by 1060.90% over the last month, potentially signaling caution among insiders.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Balchem Corporation Q2 2026 Earnings Call Highlights

Balchem Reports Strong Q2 2026 Financial Results with Record Sales and Earnings

Balchem Q2 Earnings Exceed Expectations

Balchem Corporation to Participate in CJS Securities Conference

Balchem Corporation Reports Record Q1 2026 Earnings with Growth Across Segments
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).
Balchem Corp is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $167.83, with a forward P/E ratio of 29.33, indicating growth potential. The company reported a 11.2% year-over-year revenue increase in Q2 2026, reaching $284 million, and a gross margin of 36.5%, which reflects robust profitability. However, a risk to consider is the significant insider selling, which has increased by 1060.90% over the last month, potentially signaling caution among insiders.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。